Replies to post #116320 on Biotech Values

[DewDiligence]

…here is a [hypothetical] scenario no one else has broached: what if the FDA approves both m-copaxone and t-lovenox on the same day! I think MNTA share price skyrockets once the market actually takes into account what just happened with Copaxone…

Agreed—in your wildly unlikely scenario, MNTA’s share price would go up substantially, IMO.

[zipjet]

it does appear unlikely that tenoxaparin will be approved any time soon

Some of us are on-record that it could be soon. I am in the April to Oct, 2011 camp.

Keep an eye on when TEVA gets the Israel plant cleared by the FDA. After that tL.

ij